PortViewPortView
Phreesia logo

Phreesia (PHR) Stock Analysis

NYSEHealthcareMedical - Healthcare Information Services

$12.39+0.81%
1-year price historyRange $8.06 – $23.41
52-week range$12.39
$7.77$23.87

Track PHR in your portfolio for free · Portfolio tracker

What Phreesia does

Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.

Key metrics

Market cap
$769.06M
P/E (TTM)
44.25
EPS (TTM)
$0.28
Beta
0.84
Dividend yield
0.00%
Revenue / share
$8.21
50-day avg
$11.00
200-day avg
$10.99
52-week high
$23.87
52-week low
$7.77
CEO
Chaim Indig

ETFs linked to PHR

Broad-market and Healthcare sector ETFs an investor holding Phreesia is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how PHR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PHR in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Phreesia?
Phreesia trades under the ticker PHR on NYSE.
Which exchange is PHR listed on?
PHR is listed on NYSE.
What sector does Phreesia operate in?
Phreesia is classified in the Healthcare sector (Medical - Healthcare Information Services industry).
How can PortView help analyze PHR in a portfolio?
PortView shows PHR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.